These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36494242)
1. Developing bespoke antimicrobials to combat antimicrobial resistance in low- and middle-income countries: A critical appraisal of clinical utility in the elderly. MohanaSundaram A; Sathanantham ST; Sah R; Apostolopoulos V Maturitas; 2023 Apr; 170():74-75. PubMed ID: 36494242 [No Abstract] [Full Text] [Related]
2. How Should We Manage Antimicrobial Resistance in Resource-Limited Settings? Gulleen EA; Lubwama M AMA J Ethics; 2024 May; 26(5):E373-379. PubMed ID: 38700521 [TBL] [Abstract][Full Text] [Related]
3. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility. Sharma A; Singh A; Dar MA; Kaur RJ; Charan J; Iskandar K; Haque M; Murti K; Ravichandiran V; Dhingra S J Infect Public Health; 2022 Feb; 15(2):172-181. PubMed ID: 34972026 [TBL] [Abstract][Full Text] [Related]
4. Use of Social Media as a Tool to Reduce Antibiotic Usage: A Neglected Approach to Combat Antimicrobial Resistance in Low and Middle Income Countries. Acharya KP; Subedi D Front Public Health; 2020; 8():558576. PubMed ID: 33363074 [No Abstract] [Full Text] [Related]
5. Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis. Alsan M; Schoemaker L; Eggleston K; Kammili N; Kolli P; Bhattacharya J Lancet Infect Dis; 2015 Oct; 15(10):1203-1210. PubMed ID: 26164481 [TBL] [Abstract][Full Text] [Related]
6. Interventions to address antimicrobial resistance: an ethical analysis of key tensions and how they apply in low- income and middle-income countries. Pokharel S; Adhikari B; Johnson T; Cheah PY BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38569658 [TBL] [Abstract][Full Text] [Related]
7. BSAC Vanguard Series: AMR diagnostics in light of evolving technologies and access in low- and middle-income countries. Berman D; Neale R J Antimicrob Chemother; 2021 Dec; 77(1):3-4. PubMed ID: 34791279 [TBL] [Abstract][Full Text] [Related]
8. Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh. Mahadi AR Front Public Health; 2021; 9():770593. PubMed ID: 34976929 [No Abstract] [Full Text] [Related]
9. Hospital-Based Antimicrobial Stewardship Programs Used in Low- and Middle-Income Countries: A Scoping Review. Setiawan E; Abdul-Aziz MH; Roberts JA; Cotta MO Microb Drug Resist; 2022 May; 28(5):566-584. PubMed ID: 35333607 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance in low- and middle-income countries: current status and future directions. Sulis G; Sayood S; Gandra S Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Resistance: a One Health Perspective. McEwen SA; Collignon PJ Microbiol Spectr; 2018 Mar; 6(2):. PubMed ID: 29600770 [TBL] [Abstract][Full Text] [Related]
12. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future. Godman B; Haque M; McKimm J; Abu Bakar M; Sneddon J; Wale J; Campbell S; Martin AP; Hoxha I; Abilova V; Anand Paramadhas BD; Mpinda-Joseph P; Matome M; de Lemos LLP; Sefah I; Kurdi A; Opanga S; Jakupi A; Saleem Z; Hassali MA; Kibuule D; Fadare J; Bochenek T; Rothe C; Furst J; Markovic-Pekovic V; Bojanić L; Schellack N; Meyer JC; Matsebula Z; Phuong TNT; Thanh BN; Jan S; Kalungia A; Mtapuri-Zinyowera S; Sartelli M; Hill R Curr Med Res Opin; 2020 Feb; 36(2):301-327. PubMed ID: 31794332 [No Abstract] [Full Text] [Related]
14. Using 'smart regulation' to tackle antimicrobial resistance in low-income and middle-income countries. Porter G; Joshi J; Bhullar L; Kotwani A; BMJ Glob Health; 2020; 5(1):e001864. PubMed ID: 32133168 [No Abstract] [Full Text] [Related]
15. Global trends in antimicrobial resistance in animals in low- and middle-income countries. Van Boeckel TP; Pires J; Silvester R; Zhao C; Song J; Criscuolo NG; Gilbert M; Bonhoeffer S; Laxminarayan R Science; 2019 Sep; 365(6459):. PubMed ID: 31604207 [TBL] [Abstract][Full Text] [Related]
16. Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections. Williams E; Fairley CK; Williamson D Curr Opin Infect Dis; 2021 Dec; 34(6):591-598. PubMed ID: 34545855 [TBL] [Abstract][Full Text] [Related]
18. Neisseria gonorrhoeae Antimicrobial Resistance: Past to Present to Future. Aitolo GL; Adeyemi OS; Afolabi BL; Owolabi AO Curr Microbiol; 2021 Mar; 78(3):867-878. PubMed ID: 33528603 [TBL] [Abstract][Full Text] [Related]
19. The role of poverty in antimicrobial resistance. Planta MB J Am Board Fam Med; 2007; 20(6):533-9. PubMed ID: 17954860 [TBL] [Abstract][Full Text] [Related]
20. Bidirectional effect of poverty and treatment-resistant diseases: The case of antimicrobial resistance in middle and low-income countries. Rahim F J Infect Public Health; 2024 Feb; 17(2):283-285. PubMed ID: 38141545 [No Abstract] [Full Text] [Related] [Next] [New Search]